On August 15, 2025, the U.S. Court of Appeals for the D.C. Circuit limited FDA's ability to deny a hearing on the approvability of a new drug application (NDA) based on a lack of “substantial evidence ...
Their lawyers fear the notices are merely the first step toward the removal without due process of Somali asylum applicants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results